Active Ingredient: ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Proprietary Name: VIMOVO
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: EQ 20MG BASE;500MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022511
Product Number: 001
Approval Date: Apr 30, 2010
Applicant Holder Full Name: HORIZON MEDICINES LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
